Join us for Episode 4 of GEN Live, sponsored by Tecan. In this live zoom event we discuss the state of vaccine development for COVID-19. We evaluate the front-runners, explore the potential of RNA vaccines, ponder the challenges of manufacturing, and tackle questions about herd immunity.
In this webinar from GEN and The CRISPR Journal, T.J. Cradick, PhD, —who was until recently head of genome editing at CRISPR Therapeutics—will introduce how genome editing is used to engineer cell therapies.
In this recorded GEN Live event, sponsored by PerkinElmer, we discussed the state of gene therapy, the rise of AAV, and the safety issues that need to be addressed going forward.
Cleft palates. Grievous wounds. Lost hands or faces. All could be repaired more completely than is currently possible if genetic editing were to become...
Synthego says the $110 million in Series C financing it raised this week will enable it to proceed with ambitious expansion plans that include...
Virus particles that infect bacteria can work together to overcome antiviral defences, new research shows.
Team uses mRNA-loaded carriers to target the genetic instructions of an anti-inflammatory protein in immune cells.
A technology designed to improve CRISPR-Cas9 gene editing in mosquitoes and other arthropods succeeds with a high degree of efficiency, while eliminating the need for difficult microinjection of genetic material, according to researchers.
Team invents biological switch that turns protein expression on at will
Inexpensive device can diagnose Zika in just a few hours